Literature DB >> 22139832

Estimating the agreement and diagnostic accuracy of two diagnostic tests when one test is conducted on only a subsample of specimens.

Hormuzd A Katki1, Yan Li, David W Edelstein, Philip E Castle.   

Abstract

We focus on the efficient usage of specimen repositories for the evaluation of new diagnostic tests and for comparing new tests with existing tests. Typically, all pre-existing diagnostic tests will already have been conducted on all specimens. However, we propose retesting only a judicious subsample of the specimens by the new diagnostic test. Subsampling minimizes study costs and specimen consumption, yet estimates of agreement or diagnostic accuracy potentially retain adequate statistical efficiency. We introduce methods to estimate agreement statistics and conduct symmetry tests when the second test is conducted on only a subsample and no gold standard exists. The methods treat the subsample as a stratified two-phase sample and use inverse-probability weighting. Strata can be any information available on all specimens and can be used to oversample the most informative specimens. The verification bias framework applies if the test conducted on only the subsample is a gold standard. We also present inverse-probability-weighting-based estimators of diagnostic accuracy that take advantage of stratification. We present three examples demonstrating that adequate statistical efficiency can be achieved under subsampling while greatly reducing the number of specimens requiring retesting. Naively using standard estimators that ignore subsampling can lead to drastically misleading estimates. Through simulation, we assess the finite-sample properties of our estimators and consider other possible sampling designs for our examples that could have further improved statistical efficiency. To help promote subsampling designs, our R package CompareTests computes all of our agreement and diagnostic accuracy statistics.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22139832      PMCID: PMC3809897          DOI: 10.1002/sim.4422

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  30 in total

1.  Optimal designs of two-stage studies for estimation of sensitivity, specificity and positive predictive value.

Authors:  Roseanne McNamee
Journal:  Stat Med       Date:  2002-12-15       Impact factor: 2.373

2.  A cautionary note on the robustness of latent class models for estimating diagnostic error without a gold standard.

Authors:  Paul S Albert; Lori E Dodd
Journal:  Biometrics       Date:  2004-06       Impact factor: 2.571

3.  Sample size calculations for evaluating a diagnostic test when the gold standard is missing at random.

Authors:  Andrzej S Kosinski; Ying Chen; Robert H Lyles
Journal:  Stat Med       Date:  2010-07-10       Impact factor: 2.373

4.  A sequential design to estimate sensitivity and specificity of a diagnostic or screening test.

Authors:  Lisa M Wruck; Constantin T Yiannoutsos; Michael D Hughes
Journal:  Stat Med       Date:  2006-10-30       Impact factor: 2.373

5.  A novel design for estimating relative accuracy of screening tests when complete disease verification is not feasible.

Authors:  Todd A Alonzo; John M Kittelson
Journal:  Biometrics       Date:  2006-06       Impact factor: 2.571

6.  Biases in the assessment of diagnostic tests.

Authors:  C B Begg
Journal:  Stat Med       Date:  1987-06       Impact factor: 2.373

7.  Ordinal regression methodology for ROC curves derived from correlated data.

Authors:  A Y Toledano; C Gatsonis
Journal:  Stat Med       Date:  1996-08-30       Impact factor: 2.373

8.  Assessment of diagnostic tests when disease verification is subject to selection bias.

Authors:  C B Begg; R A Greenes
Journal:  Biometrics       Date:  1983-03       Impact factor: 2.571

Review 9.  Special commentary: patient safety and the next generation of HPV DNA tests.

Authors:  Walter Kinney; Mark H Stoler; Philip E Castle
Journal:  Am J Clin Pathol       Date:  2010-08       Impact factor: 2.493

10.  Evaluation of a novel PCR-based assay for detection and identification of Chlamydia trachomatis serovars in cervical specimens.

Authors:  Koen Quint; Carolina Porras; Mahboobeh Safaeian; Paula González; Allan Hildesheim; Wim Quint; Leen-Jan van Doorn; Sandra Silva; Willem Melchers; Mark Schiffman; Ana Cecilia Rodríguez; Sholom Wacholder; Enrique Freer; Bernal Cortes; Rolando Herrero
Journal:  J Clin Microbiol       Date:  2007-10-24       Impact factor: 5.948

View more
  6 in total

1.  Performance of Administrative Algorithms to Identify Interstitial Lung Disease in Rheumatoid Arthritis.

Authors:  Bryant R England; Punyasha Roul; Tina D Mahajan; Namrata Singh; Fang Yu; Harlan Sayles; Grant W Cannon; Brian C Sauer; Joshua F Baker; Jeffrey R Curtis; Ted R Mikuls
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-10       Impact factor: 4.794

2.  Comparison of algorithm-based estimates of occupational diesel exhaust exposure to those of multiple independent raters in a population-based case-control study.

Authors:  Melissa C Friesen; Anjoeka Pronk; David C Wheeler; Yu-Cheng Chen; Sarah J Locke; Dennis D Zaebst; Molly Schwenn; Alison Johnson; Richard Waddell; Dalsu Baris; Joanne S Colt; Debra T Silverman; Patricia A Stewart; Hormuzd A Katki
Journal:  Ann Occup Hyg       Date:  2012-11-25

3.  Examining the Prevalence Rates of Preexisting Maternal Medical Conditions and Pregnancy Complications by Source: Evidence to Inform Maternal and Child Research.

Authors:  Candace A Robledo; Edwina H Yeung; Pauline Mendola; Rajeshwari Sundaram; Nansi S Boghossian; Erin M Bell; Charlotte Druschel
Journal:  Matern Child Health J       Date:  2017-04

4.  Anticipating missing reference standard data when planning diagnostic accuracy studies.

Authors:  Christiana A Naaktgeboren; Joris A H de Groot; Anne W S Rutjes; Patrick M M Bossuyt; Johannes B Reitsma; Karel G M Moons
Journal:  BMJ       Date:  2016-02-09

5.  Hepatitis E virus infection in the United States: Seroprevalence, risk factors and the influence of immunological assays.

Authors:  María Belén Pisano; Christopher Campbell; Chimaobi Anugwom; Viviana Elizabeth Ré; José D Debes
Journal:  PLoS One       Date:  2022-08-05       Impact factor: 3.752

6.  How to Analyze the Diagnostic Performance of a New Test? Explained with Illustrations.

Authors:  Deepak Dhamnetiya; Ravi Prakash Jha; Shalini Shalini; Krittika Bhattacharyya
Journal:  J Lab Physicians       Date:  2021-09-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.